CDx
Contactez-nous

Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma

Affiches Mar 5, 2025

March 5, 2025

Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma

scoring metiodd to determine inflamed, excluded or desert Immune Phenotype in Carcinoma

One global CRO for your whole therapeutic development journey

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

cta banner